Dacula, Sittie Alisha A.

HRN: 21-57-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/20/2022
08/26/2022
IVT
15mg
Q8
T/C Necrotizing Enterocolitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: